Discussant - Phase Ia/Ib dose-escalation study of the anti-TIGIT  tiragolumab as a single agent and in combination with atezolizumab in advanced solid tumors - Michele Teng #AACR20 $RHHBY $MRK $RCUS $MREO $SGEN 2/x

4 types of TMEs, TIGIT pathway
TIGIT upreagulated in CD8+ T https://t.co/dHHDevySsk